# Understanding the ARPA-H Act

The federal government is creating a brand new agency called the Advanced Research Projects Agency–Health, or ARPA-H, designed to hunt for breakthrough medical discoveries and turn them into treatments that can actually help patients. Think of it as a specialized team focused on the hard medical problems that traditional research funding hasn't solved yet—diseases where the market alone won't drive companies to develop cures because the potential profit isn't attractive enough.

Here's what ARPA-H will actually do: It will fund high-risk, high-reward research projects aimed at developing new drugs, medical devices, and biological treatments for serious diseases. The agency will have its own director, separate budget, and the flexibility to move quickly without getting bogged down in typical government bureaucracy. Instead of waiting years for results, ARPA-H will set specific milestones for projects and shut down ones that aren't working. The director can hire top scientific talent at competitive salaries, partner with universities, private companies, nonprofits, and other government agencies, and use various funding tools like grants, contracts, and even prize competitions to spur innovation.

The bill gives ARPA-H $3 billion to start in 2022 and emphasizes that it should focus on diseases where patients have real unmet needs and where commercial incentives alone won't drive development. The agency will coordinate with the Food and Drug Administration and Medicare to help get successful treatments approved and covered for patients faster. Every year, ARPA-H must report to Congress on what projects it's funding, which ones succeeded or failed, and how it's working with other government agencies to avoid duplicating efforts. After eight years, an independent evaluation will assess whether ARPA-H actually achieved its goals of revolutionizing how we diagnose and treat diseases.

ARPA–H Act

Eshoo, Anna G.

Advanced Research Project Agency-Health Act or the ARPA-H Act This bill establishes within the Department of Health and Human Services (HHS) the Advanced Research Projects Agency-Health to accelerate innovation in health and medicine by investing in high-risk, high-reward research projects. The bill also establishes an interagency committee to inform, and a fund in the Treasury to support, the agency's activities. The President must appoint from the personnel of HHS a director to lead the agency. The director may submit testimony and recommendations concerning the agency to Congress without review or approval by other federal officers or agencies. The director must designate personnel to serve as program managers who administer the agency's research programs, including by selecting projects to support, setting progress milestones for projects, and making recommendations about terminating or continuing projects. The agency may use a variety of mechanisms to support the research projects, including grants, contracts, and prize competitions. The agency's budget is separate from that of HHS. The agency must coordinate with the Food and Drug Administration and the Centers for Medicare &amp; Medicaid Services to expedite development and coverage of high-need cures. Additionally, the agency may partner with other public and private entities, such as institutions of higher education and patient advocacy organizations. The bill also requires the agency to develop and periodically update a strategic plan and annually report on its activities. Furthermore, the National Academies of Sciences, Engineering, and Medicine must evaluate the agency's performance.